Leuprolide Reference
Educational, not medical advice reference for Leuprolide: Reproductive, Hormonal; regulatory status, evidence posture, source review, and schedu…
Plain English
- What it is
- Leuprolide is an FDA-approved prescription medicine sold under brand names like Lupron Depot and Eligard. It is a GnRH agonist, meaning it is a lab-made copy of a natural hormone that, after a short early rise, lowers the body's sex hormones (testosterone in men, estrogen in women).
- What people use it for
- Doctors prescribe it for advanced prostate cancer, for endometriosis, and to improve anemia from uterine fibroids before surgery. It is also used to treat children with central precocious puberty, which is puberty that starts too early. It is given and managed by a clinician and is not a body-composition or fitness drug.
- What the science shows
- It has decades of approved-label evidence in cancer care and hormone conditions, where lowering sex hormones is the goal. Common reported side effects include hot flashes and sweats, headaches, mood changes, and weight change.
- The catch
- Because it pushes sex hormones very low, it can cause bone loss that may not fully recover, and product labels note a reported risk of heart attack, stroke, and sudden death in men. It is prescription-only and clinician-managed, so off-label or self-administered use is unsafe and outside FDA approval.
Reference summary
Leuprolide is a label-verified GnRH agonist depot with decades of approved-label evidence in oncology and endocrinology. pepSmart surfaces label-reference content only.
Regulatory and posture
- Categories
- Reproductive, Hormonal
- Aliases
- Lupron Depot, Eligard, GnRH agonist
- Evidence posture
- human - Oncology / endocrinology drug. Prescription-only, clinician-managed; off-label or self-administered use carries serious harm potential including bone-density loss, cardiovascular events, and oncology-specific concerns.
- Regulatory status
- FDA-approved prescription medication (Lupron Depot, Eligard). Indications include advanced prostate cancer, endometriosis, central precocious puberty, and uterine fibroids. Prescription-only and clinician-managed.
- Content review status
- label verified
Selected public sources
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.